Intensity Therapeutics, Inc. (INTS)
3.35
-0.03
(-0.89%)
USD |
NASDAQ |
Oct 16, 16:00
3.27
-0.08
(-2.39%)
After-Hours: 20:00
Intensity Therapeutics Total Assets (Quarterly) : 11.52M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.52M |
| March 31, 2026 | 12.29M |
| December 31, 2025 | 14.13M |
| September 30, 2025 | 9.585M |
| June 30, 2025 | 4.443M |
| March 31, 2025 | 3.065M |
| December 31, 2024 | 4.783M |
| September 30, 2024 | 5.213M |
| June 30, 2024 | 8.673M |
| March 31, 2024 | 12.41M |
| December 31, 2023 | 17.30M |
| September 30, 2023 | 16.82M |
| Date | Value |
|---|---|
| June 30, 2023 | 18.23M |
| March 31, 2023 | 0.9515M |
| December 31, 2022 | 1.757M |
| September 30, 2022 | 1.205M |
| June 30, 2022 | 2.274M |
| March 31, 2022 | 3.725M |
| December 31, 2021 | 5.216M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 8.944M |
| December 31, 2020 | 10.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.307M |
| Shareholders Equity (Quarterly) | 9.214M |
| Debt to Equity Ratio | 0.0103 |
| Current Ratio | 5.002 |
| Net Debt Paydown Yield | 0.06% |